Mount Sinai - PRIME is a clinical research site located in Jamaica, New York, United States 11432.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Mount Sinai - PRIME has participated in 1 clinical trials.
Therapeutic areas: Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction.
Sponsors: EMD Serono Research & Development Institute, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Jamaica
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mount Sinai - PRIME has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mount Sinai - PRIME has 1 clinical trials on record. Their work covers Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction.
Mount Sinai - PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.